Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries
Author
Abstract
Suggested Citation
DOI: 10.1016/j.healthpol.2014.06.001
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Joan-Ramon Borrell & Laura Fernández-Villadangos, 2010. "Clustering or scattering: the underlying reason for regulating distance among retail outlets," Working Papers XREAP2010-12, Xarxa de Referència en Economia Aplicada (XREAP), revised Dec 2010.
- Dylst, Pieter & Vulto, Arnold & Simoens, Steven, 2011. "Tendering for outpatient prescription pharmaceuticals: What can be learned from current practices in Europe?," Health Policy, Elsevier, vol. 101(2), pages 146-152, July.
- Morgall, Janine Marie & Almarsdóttir, Anna Birna, 1999. "No struggle, no strength: how pharmacists lost their monopoly," Social Science & Medicine, Elsevier, vol. 48(9), pages 1247-1258, May.
- Mossialos, Elias & Naci, Huseyin & Courtin, Emilie, 2013. "Expanding the role of community pharmacists: Policymaking in the absence of policy-relevant evidence?," Health Policy, Elsevier, vol. 111(2), pages 135-148.
- Kanavos, Panos G. & Vandoros, Sotiris, 2011.
"Determinants of branded prescription medicine prices in OECD countries,"
Health Economics, Policy and Law, Cambridge University Press, vol. 6(3), pages 337-367, July.
- Kanavos, Panos & Vandoros, Sotiris, 2011. "Determinants of branded prescription medicine prices in OECD countries," LSE Research Online Documents on Economics 36351, London School of Economics and Political Science, LSE Library.
- Paudyal, Vibhu & Hansford, Denise & Cunningham, Scott & Stewart, Derek, 2011. "Pharmacy assisted patient self care of minor ailments: A chronological review of UK health policy documents and key events 1997-2010," Health Policy, Elsevier, vol. 101(3), pages 253-259, August.
- Bernsten, Cecilia & Andersson, Karolina & Gariepy, Yves & Simoens, Steven, 2010. "A comparative analysis of remuneration models for pharmaceutical professional services," Health Policy, Elsevier, vol. 95(1), pages 1-9, April.
- Brekke, Kurt Richard & Holmås, Tor Helge & Straume, Odd Rune, 2013.
"Margins and market shares: Pharmacy incentives for generic substitution,"
European Economic Review, Elsevier, vol. 61(C), pages 116-131.
- Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2010. "Margins and Market Shares:Pharmacy Incentives for Generic Substitution," NIPE Working Papers 20/2010, NIPE - Universidade do Minho.
- Brekke, Kurt Richard & Holmås, Tor Helge & Straume, Odd Rune, 2010. "Margins and Market Shares: Pharmacy Incentives for Generic Substitution," Discussion Paper Series in Economics 18/2010, Norwegian School of Economics, Department of Economics.
- Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2012. "Margins and Market Shares: Pharmacy Incentives for Generic Substitution," CESifo Working Paper Series 4055, CESifo.
- Leopold, Christine & Mantel-Teeuwisse, Aukje Katja & Vogler, Sabine & de Joncheere, Kees & Laing, Richard Ogilvie & Leufkens, Hubert G.M., 2013. "Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries," Health Policy, Elsevier, vol. 112(3), pages 209-216.
- Mossialos, Elias & Mrazek, Monique F., 2003. "The regulation of pharmacies in six countries: report prepared for the Office of Fair Trading," LSE Research Online Documents on Economics 22505, London School of Economics and Political Science, LSE Library.
- Paul Gorecki, 2011. "Do you believe in magic? Improving the quality of pharmacy services through restricting entry and aspirational contracts, the Irish experience," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 12(6), pages 521-531, December.
- Silcock, Jonathan & Raynor, D. K. Theo & Petty, Duncan, 2004. "The organisation and development of primary care pharmacy in the United Kingdom," Health Policy, Elsevier, vol. 67(2), pages 207-214, February.
- Larsen, Jakob Bjerg & Vrangbæk, Karsten & Traulsen, Janine M., 2006. "Advocacy coalitions and pharmacy policy in Denmark--Solid cores with fuzzy edges," Social Science & Medicine, Elsevier, vol. 63(1), pages 212-224, July.
- Schafheutle, Ellen Ingrid & Seston, Elizabeth Mary & Hassell, Karen, 2011. "Factors influencing pharmacist performance: A review of the peer-reviewed literature," Health Policy, Elsevier, vol. 102(2), pages 178-192.
- Bardage, Carola & Westerlund, Tommy & Barzi, Sahra & Bernsten, Cecilia, 2013. "Non-prescription medicines for pain and fever—A comparison of recommendations and counseling from staff in pharmacy and general sales stores," Health Policy, Elsevier, vol. 110(1), pages 76-83.
- Stargardt, Tom & Schreyögg, Jonas & Busse, Reinhard, 2007. "Pricing behaviour of pharmacies after market deregulation for OTC drugs: The case of Germany," Health Policy, Elsevier, vol. 84(1), pages 30-38, November.
- Lluch, Maria & Kanavos, Panos, 2010. "Impact of regulation of Community Pharmacies on efficiency, access and equity. Evidence from the UK and Spain," Health Policy, Elsevier, vol. 95(2-3), pages 245-254, May.
- Rudholm, Niklas, 2008. "Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--Consequences for costs and availability," Health Policy, Elsevier, vol. 87(2), pages 258-263, August.
- Anell, Anders, 2005. "Deregulating the pharmacy market: the case of Iceland and Norway," Health Policy, Elsevier, vol. 75(1), pages 9-17, December.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Vogler, Sabine & Zimmermann, Nina & de Joncheere, Kees, 2016. "Policy interventions related to medicines: Survey of measures taken in European countries during 2010–2015," Health Policy, Elsevier, vol. 120(12), pages 1363-1377.
- Bruno, Giuseppe & Cavola, Manuel & Diglio, Antonio & Elizalde, Javier & Piccolo, Carmela, 2022. "A locational analysis of deregulation policies in the Spanish retail pharmaceutical sector," Socio-Economic Planning Sciences, Elsevier, vol. 82(PA).
- Jo, Wooyong & Nam, Hyoryung & Choi, Jeonghye, 2022. "Opening the OTC drug market: The effect of deregulation on retail pharmacy’s performance," International Journal of Research in Marketing, Elsevier, vol. 39(3), pages 847-866.
- Moura, Ana, 2021. "Essays in health economics," Other publications TiSEM c93abd22-fa4a-42a5-b172-d, Tilburg University, School of Economics and Management.
- Ana Moura & Pedro Pita Barros, 2020. "Entry and price competition in the over‐the‐counter drug market after deregulation: Evidence from Portugal," Health Economics, John Wiley & Sons, Ltd., vol. 29(8), pages 865-877, August.
- Gallone, Emma Luisa & Ravetto Enri, Lorenzo & Pignata, Irene & Baratta, Francesca & Brusa, Paola, 2020. "The 2017 deregulation of pharmacies in Italy: Introducing non-pharmacist ownership," Health Policy, Elsevier, vol. 124(12), pages 1281-1286.
- Martins, Lurdes & Queirós, Sónia, 2015. "Competition among pharmacies and the typology of services delivered: The Portuguese case," Health Policy, Elsevier, vol. 119(5), pages 640-647.
- Barbarisi, Ilaria & Bruno, Giuseppe & Diglio, Antonio & Elizalde, Javier & Piccolo, Carmela, 2019. "A spatial analysis to evaluate the impact of deregulation policies in the pharmacy sector: Evidence from the case of Navarre," Health Policy, Elsevier, vol. 123(11), pages 1108-1115.
- Kališ, Richard, 2024. "From symbiosis to independence: Investigating changes in the relationship between general practitioners’ presence and pharmacies’ market size in Slovakia," Health Policy, Elsevier, vol. 143(C).
- Håkonsen, Helle & Sundell, Karolina Andersson & Martinsson, Johan & Hedenrud, Tove, 2016. "Consumer preferences for over-the-counter drug retailers in the reregulated Swedish pharmacy market," Health Policy, Elsevier, vol. 120(3), pages 327-333.
- Marcin Wiśniewski & Urszula Religioni & Piotr Merks, 2020. "Community Pharmacies in Poland—The Journey from a Deregulated to a Strictly Regulated Market," IJERPH, MDPI, vol. 17(23), pages 1-11, November.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Barbarisi, Ilaria & Bruno, Giuseppe & Diglio, Antonio & Elizalde, Javier & Piccolo, Carmela, 2019. "A spatial analysis to evaluate the impact of deregulation policies in the pharmacy sector: Evidence from the case of Navarre," Health Policy, Elsevier, vol. 123(11), pages 1108-1115.
- Ana Moura & Pedro Pita Barros, 2020. "Entry and price competition in the over‐the‐counter drug market after deregulation: Evidence from Portugal," Health Economics, John Wiley & Sons, Ltd., vol. 29(8), pages 865-877, August.
- Moura, Ana, 2021. "Essays in health economics," Other publications TiSEM c93abd22-fa4a-42a5-b172-d, Tilburg University, School of Economics and Management.
- Andrea Cintolesi & Andrea Riganti, 2022. "Liberalizing the opening of new pharmacies and hospitalizations," Temi di discussione (Economic working papers) 1388, Bank of Italy, Economic Research and International Relations Area.
- Jo, Wooyong & Nam, Hyoryung & Choi, Jeonghye, 2022. "Opening the OTC drug market: The effect of deregulation on retail pharmacy’s performance," International Journal of Research in Marketing, Elsevier, vol. 39(3), pages 847-866.
- Gallone, Emma Luisa & Ravetto Enri, Lorenzo & Pignata, Irene & Baratta, Francesca & Brusa, Paola, 2020. "The 2017 deregulation of pharmacies in Italy: Introducing non-pharmacist ownership," Health Policy, Elsevier, vol. 124(12), pages 1281-1286.
- Lluch, Maria & Kanavos, Panos, 2010. "Impact of regulation of Community Pharmacies on efficiency, access and equity. Evidence from the UK and Spain," Health Policy, Elsevier, vol. 95(2-3), pages 245-254, May.
- Guhl, Dennis & Stargardt, Tom & Schneider, Udo & Fischer, Katharina E., 2016. "Dispensing behaviour of pharmacies in prescription drug markets," Health Policy, Elsevier, vol. 120(2), pages 190-197.
- Håkonsen, Helle & Sundell, Karolina Andersson & Martinsson, Johan & Hedenrud, Tove, 2016. "Consumer preferences for over-the-counter drug retailers in the reregulated Swedish pharmacy market," Health Policy, Elsevier, vol. 120(3), pages 327-333.
- Vogler, Sabine & Zimmermann, Nina & de Joncheere, Kees, 2016. "Policy interventions related to medicines: Survey of measures taken in European countries during 2010–2015," Health Policy, Elsevier, vol. 120(12), pages 1363-1377.
- Gerald J. Pruckner & Thomas Schober, 2018.
"Hospitals and the generic versus brand‐name prescription decision in the outpatient sector,"
Health Economics, John Wiley & Sons, Ltd., vol. 27(8), pages 1264-1283, August.
- Gerald J. Pruckner & Thomas Schober, 2016. "Hospitals and the generic versus brand-name prescription decision in the outpatient sector," CDL Aging, Health, Labor working papers 2016-05, The Christian Doppler (CD) Laboratory Aging, Health, and the Labor Market, Johannes Kepler University Linz, Austria.
- Gerald J. Pruckner & Thomas Schober, 2016. "Hospitals and the generic versus brand-name prescription decision in the outpatient sector," Economics working papers 2016-11, Department of Economics, Johannes Kepler University Linz, Austria.
- Fontrier, Anna-Maria & Gill, Jennifer & Kanavos, Panos, 2019. "International impact of external reference pricing: should national policy makers care?," LSE Research Online Documents on Economics 100929, London School of Economics and Political Science, LSE Library.
- Anna-Maria Fontrier & Jennifer Gill & Panos Kanavos, 2019. "International impact of external reference pricing: should national policy-makers care?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(8), pages 1147-1164, November.
- Kališ, Richard, 2024. "From symbiosis to independence: Investigating changes in the relationship between general practitioners’ presence and pharmacies’ market size in Slovakia," Health Policy, Elsevier, vol. 143(C).
- Bruno, Giuseppe & Cavola, Manuel & Diglio, Antonio & Elizalde, Javier & Piccolo, Carmela, 2022. "A locational analysis of deregulation policies in the Spanish retail pharmaceutical sector," Socio-Economic Planning Sciences, Elsevier, vol. 82(PA).
- Birg, Laura, 2019. "Parallel imports and manufacturer rebates: Evidence from Germany," University of Göttingen Working Papers in Economics 363, University of Goettingen, Department of Economics.
- Bergman , Mats A. & Granlund, David & Rudholm, Niklas, 2016. "Squeezing the last drop out of your suppliers: an empirical study of market-based purchasing policies for generic pharmaceuticals," Umeå Economic Studies 921, Umeå University, Department of Economics.
- Adrian Towse & Michele Pistollato & Jorge Mestre-Ferrandiz & Zeba Khan & Satyin Kaura & Louis Garrison, 2015. "European Union Pharmaceutical Markets: A Case for Differential Pricing?," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 263-275, July.
- Håkonsen, Helle & Horn, Anne Marie & Toverud, Else-Lydia, 2009. "Price control as a strategy for pharmaceutical cost containment--What has been achieved in Norway in the period 1994-2004?," Health Policy, Elsevier, vol. 90(2-3), pages 277-285, May.
- Pierre Dubois & Morten Sæthre, 2020.
"On the Effect of Parallel Trade on Manufacturers' and Retailers' Profits in the Pharmaceutical Sector,"
Econometrica, Econometric Society, vol. 88(6), pages 2503-2545, November.
- Dubois, Pierre & Sæthre, Morten, 2017. "On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector," Discussion Paper Series in Economics 3/2018, Norwegian School of Economics, Department of Economics.
- Pierre Dubois & Morten Sæthre, 2020. "On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector," Post-Print hal-03176406, HAL.
- Dubois, Pierre & Saethre, Morten, 2018. "On the Effect of Parallel Trade on Manufacturers’ and Retailers’ Profits in the Pharmaceutical Sector," TSE Working Papers 18-883, Toulouse School of Economics (TSE), revised Mar 2020.
- Dubois, Pierre & Saethre, Morten, 2018. "On the Effect of Parallel Trade on Manufacturers' and Retailers' Profits in the Pharmaceutical Sector," CEPR Discussion Papers 12649, C.E.P.R. Discussion Papers.
More about this item
Keywords
Community pharmacy; Europe; Deregulation; Policy change;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:117:y:2014:i:3:p:311-327. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.